|
Model Number 97800 |
Device Problems
High impedance (1291); Therapeutic or Diagnostic Output Failure (3023)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/08/2024 |
Event Type
malfunction
|
Manufacturer Narrative
|
G2: country united kingdom medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Information was received from a healthcare provider regarding a patient who was implanted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that healthcare professional (hcp) had a patient who received an interstim x last week.Hcp was currently programming the interstim x, but when they performed the impedance check, all impedances turned out to be high.While setting the amplitude, hcp was prompted with the maximum settings/out of regulation (oor) message.The oor was prompted at 0.5ma.It was discussed that oor occurs if the ins hardware is unable to output the stimulation at the requested parameter settings.In case of an oor, stimulation is still on, but the amplitude delivered may be at equal or lower value than on the screen appears.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received.The manufacturer representative (rep) reported a discussion took place with hcp, will be monitoring the patients symptoms over the next few months.
|
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information was received from a manufacturer representative (rep).The rep reported that there is no further information to provide.They also noted the patient is managing their symptoms.
|
|
Search Alerts/Recalls
|
|
|